 |
|
|
| |
Virologic Outcomes by ART Initiation Timing:
Sub-Analysis of the REVIVE Study (DTG/3TC & BIC/F/TAF)
|
| |
| |
IDSA 2026 October 21-24 Wash DC
Kuretski, J.1, Bolivar, H. 1, Ha, B.2, Patel, P.2, Patarroyo, J. 2, Harper, G. 3, Naylor, R. 3, Taylor-Whiteley, T. 3 & Ramgopal, M. 1
1Midway Specialty Care Center, 2ViiV Healthcare, 3Adelphi Real World, Bollington, UK
|
| |
|
|
|
|
|
